Showing 1-1 of 1 :
From Big Data to Measurable Outcomes: Aligning Stakeholder Needs for Value Based Contracts

A heightened focus on value is driving efforts across health care to improve outcomes and reduce costs. For pharmaceutical companies, this focus translates into a shift away from traditional payment models to more outcomes-based, risk sharing agreements. In many ways, these agreements present the opportunity to better align interests across health care’s stakeholders. However, they[…]